Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Look-back study of Hepatitis C in teenagers after blood transfusions as neonates.

Kori M, Flidel-Rimon O, Sigler E, Shinwell E, Granot E.

Acta Paediatr. 2007 Jul;96(7):1050-2. Epub 2007 May 10.

PMID:
17498189
2.

Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.

O'Riordan JM, Conroy A, Nourse C, Yap PL, McDonald GS, Kaminski G, Leong K, Lawlor E, Davoren A, Strong K, Davidson F, Lloyd A, Power J.

Transfus Med. 1998 Dec;8(4):303-8.

PMID:
9881424
3.
4.

Risk of hepatitis C virus infection in multiply transfused premature neonates.

Beeby PJ, Spencer JD, Cossart YE.

J Paediatr Child Health. 2001 Jun;37(3):244-6.

PMID:
11468038
5.

Blood recipient notification for hepatitis C in Prince Edward Island.

Van Til LD, Sweet LE.

CMAJ. 2000 Jan 25;162(2):199-202.

6.

Results of a general hepatitis C lookback program for persons who received blood transfusions in a neonatal intensive care unit between January 1975 and July 1992.

Cagle HH, Jacob J, Homan CE, Williams JL, Christensen CJ, McMahon BJ.

Arch Pediatr Adolesc Med. 2007 Feb;161(2):125-30.

PMID:
17283296
7.

Changing prevalence of hepatitis C virus infection among teenagers in an endemic area in Taiwan.

Huang CF, Huang JF, Dai CY, Yu ML, Lu SN, Hsieh MY, Lee LP, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL.

Trans R Soc Trop Med Hyg. 2008 Sep;102(9):929-34. doi: 10.1016/j.trstmh.2008.05.018. Epub 2008 Jul 7.

PMID:
18603274
8.

Long-term outcome (35 years) of hepatitis C after acquisition of infection through mini transfusions of blood given at birth.

Casiraghi MA, De Paschale M, Romanò L, Biffi R, Assi A, Binelli G, Zanetti AR.

Hepatology. 2004 Jan;39(1):90-6.

PMID:
14752827
9.

A Canadian hospital-based HIV/hepatitis C look-back notification program.

Heddle N, Kelton JG, Smaill F, Foss K, Everson J, Janzen C, Walker C, Jones M, Hammons D.

CMAJ. 1997 Jul 15;157(2):149-54.

10.

Look-back screening for the identification of transfusion-induced hepatitis C virus infection in Sweden.

Ydreborg M, Söderström A, Håkanson A, Alsiö A, Arnholm B, Malmström P, Hellstrand K, Westin J, Lagging M.

Scand J Infect Dis. 2011 Jul;43(6-7):522-7. doi: 10.3109/00365548.2011.562526. Epub 2011 Mar 7.

PMID:
21375426
11.

The epidemiology of transfusion-associated hepatitis C in a children's hospital.

Luban NL, Colvin CA, Mohan P, Alter HJ.

Transfusion. 2007 Apr;47(4):615-20.

PMID:
17381619
12.

High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.

Said ZN, El-Sayed MH, El-Bishbishi IA, El-Fouhil DF, Abdel-Rheem SE, El-Abedin MZ, Salama II.

Liver Int. 2009 Apr;29(4):518-24. doi: 10.1111/j.1478-3231.2009.01975.x. Epub 2009 Jan 22.

PMID:
19192168
13.

Prevalence of hepatitis C infection in adult patients who underwent congenital heart surgery prior to screening in 1992.

Wang A, Book WM, McConnell M, Lyle T, Rodby K, Mahle WT.

Am J Cardiol. 2007 Oct 15;100(8):1307-9. Epub 2007 Jul 25.

PMID:
17920376
14.

[Chronic hepatitis C virus infection and associated liver disease among the inmates of a Spanish prison].

Murcia J, Portilla J, Bedia M, Palazón JM, Sánchez-Payá J, Saiz de la Hoya P, Payá A, Boix V, Merino E, Reus S.

Enferm Infecc Microbiol Clin. 2009 Apr;27(4):206-12. doi: 10.1016/j.eimc.2008.07.003. Epub 2009 Feb 25. Spanish.

PMID:
19246126
15.

Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?

Villar LM, de Melo MM, Calado IA, de Almeida AJ, Lampe E, Gaspar AM.

J Gastroenterol Hepatol. 2009 Feb;24(2):238-42. doi: 10.1111/j.1440-1746.2008.05575.x.

PMID:
19215334
16.

[Prevalence of hepatitis C virus infection in Morocco and serological tests assessment of detection for the viremia prediction].

Benouda A, Boujdiya Z, Ahid S, Abouqal R, Adnaoui M.

Pathol Biol (Paris). 2009 Jul;57(5):368-72. doi: 10.1016/j.patbio.2008.07.006. Epub 2008 Oct 7. French.

PMID:
18842351
17.

An evaluation of the process and costs associated with targeted lookbacks for HCV and general notification of transfusion recipients.

Callum JL, Pinkerton PH, Coovadia AS, Thomson AE, Dewsbury F.

Transfusion. 2000 Oct;40(10):1169-75.

PMID:
11061851
18.

Outcomes of a Hepatitis C screening program at a large urban VA medical center.

Groom H, Dieperink E, Nelson DB, Garrard J, Johnson JR, Ewing SL, Stockley H, Durfee J, Jonk Y, Willenbring ML, Ho SB.

J Clin Gastroenterol. 2008 Jan;42(1):97-106.

PMID:
18097298
19.

Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.

Calderón GM, González-Velázquez F, González-Bonilla CR, Novelo-Garza B, Terrazas JJ, Martínez-Rodríguez ML, Cortés-Márquez SR, Blanco-Flores JP, Rodríguez-Rodríguez A, Del Campo MA, Cortés-Gómez R, Mejía-Bocanegra MG.

Transfusion. 2009 Oct;49(10):2200-7. doi: 10.1111/j.1537-2995.2009.02248.x. Epub 2009 Jun 15.

PMID:
19538543
20.

High prevalence of hepatitis C virus infection in the largest province of Pakistan.

Idrees M, Lal A, Naseem M, Khalid M.

J Dig Dis. 2008 May;9(2):95-103. doi: 10.1111/j.1751-2980.2008.00329.x.

PMID:
18419643

Supplemental Content

Support Center